{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T13:03:39Z","timestamp":1774530219276,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T00:00:00Z","timestamp":1593648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T00:00:00Z","timestamp":1593648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["103-2410-H-003-022"],"award-info":[{"award-number":["103-2410-H-003-022"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Aims<\/jats:title>\n                <jats:p>The study aims were to investigate adherence to methadone maintenance treatment (MMT) and to identify associated clinical factors in patients who inject drugs diagnosed with human immunodeficiency virus (HIV) infection in Taiwan.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Data were from the National Health Surveillance System on HIV and the National Drug Treatment System on MMT. HIV-positive people who inject drugs (HIVPWID) were defined as the study population. Information obtained included age, sex, education, marital status, employment, methadone dose, and date of diagnosis of HIV infection. Adherence was defined as taking methadone for the past 90, 180 and 365\u2009days, then categorized as high (&gt;\u200990%), moderate (51 to 90%), or low (&lt;=50%) adherent respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of 1641 HIVPWID registered in the datasets from 2007 to 2012, 961 (58.56%) had received MMT. For HIVPWID evaluated at 90\u2009days (<jats:italic>n<\/jats:italic>\u2009=\u2009951), 271 (28.5%), 382 (40.2%), and 298 (31.3%) were classified as high, moderate, and low adherent respectively. For HIVPWID evaluated at 180\u2009days (<jats:italic>n<\/jats:italic>\u2009=\u2009936), 190 (20.3%), 349 (37.3%), and 397 (42.4%) were classified as high, moderate, and low adherent respectively. For HIVPWID evaluated at 365\u2009days (<jats:italic>n<\/jats:italic>\u2009=\u2009919), 133 (14.5%), 271 (29.5%), and 515 (56.0%) were classified as high, moderate, and low adherent respectively. After controlling for sociodemographics, results showed that methadone dose, location of MMT clinic, and date of HIV diagnosis were significantly associated with MMT adherence.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Study findings underscore the importance to MMT adherence of methadone dosage, early diagnosis of patient\u2019s HIV infection, and area of patient residence.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12888-020-02764-0","type":"journal-article","created":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T09:25:31Z","timestamp":1593681931000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Adherence among HIV-positive injection drug users undergoing methadone treatment in Taiwan"],"prefix":"10.1186","volume":"20","author":[{"given":"En","family":"Chao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Chun","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Po","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Chien Jacob","family":"Ku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qurat Ul","family":"Ain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David S.","family":"Metzger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2574-3372","authenticated-orcid":false,"given":"Tony Szu-Hsien","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,2]]},"reference":[{"key":"2764_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2018.08.025","volume":"193","author":"M Auriacombe","year":"2018","unstructured":"Auriacombe M, Moriceau S, Serre F, Denis C, Micoulaud-Franchi JA, de Sevin E, Bonhomme E, Bioulac S, Fatseas M, Philip P. Development and validation of a virtual agent to screen tobacco and alcohol use disorders. Drug Alcohol Depend. 2018;193:1\u20136.","journal-title":"Drug Alcohol Depend"},{"key":"2764_CR2","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1007\/s10461-018-2226-y","volume":"23","author":"B Barker","year":"2019","unstructured":"Barker B, Adams E, Wood E, Kerr T, DeBeck K, Dong H, Shoveller J, Montaner J, Milloy MJ. Engagement in maximally-assisted therapy and adherence to antiretroviral therapy among a cohort of indigenous people who use illicit drugs. AIDS Behav. 2019;23:1258\u201366.","journal-title":"AIDS Behav"},{"issue":"sup1","key":"2764_CR3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1080\/09540120412301315259","volume":"16","author":"D Brief","year":"2004","unstructured":"Brief D, Bollinger J, Vielhauer AR, Berger-Greenstein MJ, Morgan JA, Brady EE, Buondonno SM, Keane LM, T. M. & For The Hiv\/aids Treatment Adherence, Health Outcomes And Cost Study Group. Understanding the interface of HIV, trauma, post-trauMMTic stress disorder, and substance use and its implications for health outcomes. AIDS Care. 2004;16(sup1):97\u2013120. https:\/\/doi.org\/10.1080\/09540120412301315259.","journal-title":"AIDS Care"},{"key":"2764_CR4","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/1471-244X-13-190","volume":"13","author":"YC Chou","year":"2013","unstructured":"Chou YC, Shih SF, Tsai WD, Li CS, Xu K, Lee TS. Improvement of quality of life in methadone treatment patients in northern Taiwan: a follow-up study. BMC Psychiatry. 2013;13:190.","journal-title":"BMC Psychiatry"},{"key":"2764_CR5","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1111\/j.1360-0443.2005.01232.x","volume":"100","author":"EC Donny","year":"2005","unstructured":"Donny EC, Brasser SM, Bigelow GE, Stitzer ML, Walsh SL. Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers. Addiction. 2005;100:1496\u2013509.","journal-title":"Addiction"},{"key":"2764_CR6","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.drugalcdep.2014.01.008","volume":"137","author":"S Dvoriak","year":"2014","unstructured":"Dvoriak S, Karachevsky A, Chhatre S, Booth R, Metzger D, Schumacher J, Chychula N, Pecoraro A, Woody G. Methadone maintenance for HIV positive and HIV negative patients in Kyiv: acceptability and treatment response. Drug Alcohol Depend. 2014;137:62\u20137.","journal-title":"Drug Alcohol Depend"},{"key":"2764_CR7","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1136\/hrt.2006.100180","volume":"93","author":"S Fanoe","year":"2007","unstructured":"Fanoe S, Hvidt C, Ege P, Jensen GB. Syncope and QT prolongation among patients treated with methadone for heroin dependence in the city of Copenhagen. Heart. 2007;93:1051\u20135.","journal-title":"Heart"},{"key":"2764_CR8","doi-asserted-by":"crossref","unstructured":"Gowing L, Farrell MF, Bornemann R, Sullivan LE, Ali R. Oral substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database of SysteMMTic Reviews. 2011;8:Cd004145.","DOI":"10.1002\/14651858.CD004145.pub4"},{"key":"2764_CR9","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1186\/1471-2458-11-650","volume":"11","author":"K Groh","year":"2011","unstructured":"Groh K, Audet CM, Baptista A, Sidat M, Vergara A, Vermund SH, Moon TD. Barriers to antiretroviral therapy adherence in rural Mozambique. BMC Public Health. 2011;11:650.","journal-title":"BMC Public Health"},{"key":"2764_CR10","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1600-0447.1990.tb03057.x","volume":"82","author":"L Gronbladh","year":"1990","unstructured":"Gronbladh L, Ohlund LS, Gunne LM. Mortality in heroin addiction: impact of methadone treatment. Acta Psychiatr Scand. 1990;82:223\u20137.","journal-title":"Acta Psychiatr Scand"},{"key":"2764_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12954-017-0189-3","volume":"14","author":"K Hayashi","year":"2017","unstructured":"Hayashi K, Ti L, Ayutthaya PPN, Suwannawong P, Kaplan K, Small W, Kerr T. Barriers to retention in methadone maintenance therapy among people who inject drugs in Bangkok, Thailand: a mixed-methods study. Harm Reduct Journal. 2017;14:63.","journal-title":"Harm Reduct Journal"},{"key":"2764_CR12","first-page":"255","volume":"35","author":"H Jiang","year":"2014","unstructured":"Jiang H, Cao X, Wang C, Luo W, Li J, Rou K, Zhang B, Fang Y, Li C, Wu Z. Study on the adherence and related determinants among HIV-positive clients under methadone maintenance treatment in Dali,Yunnan province from 2005 to 2013. Zhonghua Liu Xing Bing Xue Za Zhi. 2014;35:255\u20138.","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"2764_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.12.021","volume":"161","author":"G Kourounis","year":"2016","unstructured":"Kourounis G, Richards BD, Kyprianou E, Symeonidou E, Malliori MM, Samartzis L. Opioid substitution therapy: lowering the treatment thresholds. Drug Alcohol Depend. 2016;161:1\u20138.","journal-title":"Drug Alcohol Depend"},{"key":"2764_CR14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1747-597X-6-6","volume":"6","author":"TS Lee","year":"2011","unstructured":"Lee TS, Shen HC, Wu WH, Huang CW, Yen MY, Wang BE, Chuang P, Shih CY, Chou YC, Liu YL. Clinical characteristics and risk behavior as a function of HIV status among heroin users enrolled in methadone treatment in northern Taiwan. Substance Abuse Treatment Prevention Policy. 2011;6:6.","journal-title":"Substance Abuse Treatment Prevention Policy"},{"key":"2764_CR15","doi-asserted-by":"publisher","first-page":"e0123687","DOI":"10.1371\/journal.pone.0123687","volume":"10","author":"CK Lin","year":"2015","unstructured":"Lin CK, Hung CC, Peng CY, Chao E, Lee TS. Factors associated with methadone treatment duration: a cox regression analysis. PLoS One. 2015;10:e0123687.","journal-title":"PLoS One"},{"key":"2764_CR16","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1080\/09540121.2016.1259452","volume":"29","author":"D Liu","year":"2017","unstructured":"Liu D, Gu J, Xu H, Hao C, Jiao M, Zhang X, Zhao Y, Andrew B, Hao Y. Club drugs and alcohol abuse predicted dropout and poor adherence among methadone maintenance treatment patients in Guangzhou, China. AIDS Care. 2017;29:458\u201363.","journal-title":"AIDS Care"},{"key":"2764_CR17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.drugalcdep.2015.10.001","volume":"157","author":"C Marienfeld","year":"2015","unstructured":"Marienfeld C, Liu P, Wang X, Schottenfeld R, Zhou W, Chawarski MC. Evaluation of an implementation of methadone maintenance treatment in China. Drug Alcohol Depend. 2015;157:60\u20137.","journal-title":"Drug Alcohol Depend"},{"key":"2764_CR18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/02791072.1999.10471730","volume":"31","author":"S Maxwell","year":"1999","unstructured":"Maxwell S, Shinderman M. Optimizing response to methadone maintenance treatment: use of higher-dose methadone. J Psychoactive Drugs. 1999;31:95\u2013102.","journal-title":"J Psychoactive Drugs"},{"issue":"Suppl 1","key":"2764_CR19","doi-asserted-by":"publisher","first-page":"S89","DOI":"10.1086\/429503","volume":"41","author":"EF McCance-Katz","year":"2005","unstructured":"McCance-Katz EF. Treatment of opioid dependence and coinfection with HIV and hepatitis C virus in opioid-dependent patients: the importance of drug interactions between opioids and antiretroviral agents. Clin Infect Dis. 2005;41(Suppl 1):S89\u201395.","journal-title":"Clin Infect Dis"},{"key":"2764_CR20","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1001\/archpsyc.1981.01780330043004","volume":"38","author":"WH McGlothlin","year":"1981","unstructured":"McGlothlin WH, Anglin MD. Shutting off methadone. Costs and benefits. Arch Gen Psychiatry. 1981;38:885\u201392.","journal-title":"Arch Gen Psychiatry"},{"key":"2764_CR21","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1001\/jama.284.13.1689","volume":"284","author":"AT McLellan","year":"2000","unstructured":"McLellan AT, Lewis DC, O'Brien CP, Kleber HD. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA. 2000;284:1689\u201395.","journal-title":"JAMA"},{"key":"2764_CR22","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0140-6736(79)91550-2","volume":"2","author":"RG Newman","year":"1979","unstructured":"Newman RG, Whitehill WB. Double-blind comparison of methadone and placebo maintenance treatments of narcotic addicts in Hong Kong. Lancet. 1979;2:485\u20138.","journal-title":"Lancet"},{"key":"2764_CR23","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.jpsychores.2006.03.010","volume":"61","author":"B Olley","year":"2006","unstructured":"Olley B, Seedat S, Stein DJ. Persistence of psychiatric disorders in a cohort of HIV\/AIDS patients in South Africa: a 6-month follow-up study. J PsychosoMMTic Res. 2006;61:479\u201384.","journal-title":"J PsychosoMMTic Res"},{"key":"2764_CR24","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.drugalcdep.2006.02.003","volume":"84","author":"A Palepu","year":"2006","unstructured":"Palepu A, Tyndall MW, Joy R, Kerr T, Wood E, Press N, Hogg RS, Montaner JS. Antiretroviral adherence and HIV treatment outcomes among HIV\/HCV co-infected injection drug users: the role of methadone maintenance therapy. Drug Alcohol Depend. 2006;84:188\u201394.","journal-title":"Drug Alcohol Depend"},{"key":"2764_CR25","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1007\/s10461-013-0584-z","volume":"18","author":"H Reddon","year":"2014","unstructured":"Reddon H, Milloy MJ, Simo A, Montaner J, Wood E, Kerr T. Methadone maintenance therapy decreases the rate of antiretroviral therapy discontinuation among HIV-positive illicit drug users. AIDS Behav. 2014;18:740\u20136.","journal-title":"AIDS Behav"},{"key":"2764_CR26","doi-asserted-by":"publisher","first-page":"204","DOI":"10.4081\/jphr.2014.204","volume":"3","author":"G Reid","year":"2014","unstructured":"Reid G, Sharma M, Higgs P. The long winding road of opioid substitution therapy implementation in South-East Asia: challenges to scale up. J Public Health Res. 2014;3:204.","journal-title":"J Public Health Res"},{"key":"2764_CR27","doi-asserted-by":"publisher","first-page":"4097","DOI":"10.2174\/13816128113199990623","volume":"20","author":"P Roux","year":"2014","unstructured":"Roux P, Lions C, Michel L, Cohen J, Mora M, Marcellin F, Spire B, Morel A, Carrieri PM, Karila L. Predictors of non-adherence to methadone maintenance treatment in opioid-dependent individuals: implications for clinicians. Curr Pharm Des. 2014;20:4097\u2013105.","journal-title":"Curr Pharm Des"},{"key":"2764_CR28","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/add.14059","volume":"113","author":"A Russolillo","year":"2018","unstructured":"Russolillo A, Moniruzzaman A, McCandless LC, Patterson M, Somers JM. Associations between methadone maintenance treatment and crime: a 17-year longitudinal cohort study of Canadian provincial offenders. Addiction. 2018;113:656\u201367.","journal-title":"Addiction"},{"key":"2764_CR29","first-page":"287","volume":"47","author":"V Sharma","year":"2016","unstructured":"Sharma V, Chamroonswasdi K, Srisorrachatr S. Rate of adhernce to and factors associated with methadone maintenance treatment program (MMTP) compliance among injecting drug use patients in Nepal. Southeast Asian J Trop Med Public Health. 2016;47:287\u201398.","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"2764_CR30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/ADM.0000000000000180","volume":"10","author":"J Shen","year":"2016","unstructured":"Shen J, Wang M, Wang X, Zhang G, Guo J, Li X, Li J. Predictors of poor adherence to methadone maintenance treatment in Yunnan Province, China. J Addict Med. 2016;10:40\u20135.","journal-title":"J Addict Med"},{"key":"2764_CR31","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1001\/jama.281.11.1000","volume":"281","author":"EC Strain","year":"1999","unstructured":"Strain EC, Bigelow GE, Liebson IA, Stitzer ML. Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial. JAMA. 1999;281:1000\u20135.","journal-title":"JAMA"},{"key":"2764_CR32","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/j.1360-0443.2004.00963.x","volume":"100","author":"LE Sullivan","year":"2005","unstructured":"Sullivan LE, Metzger DS, Fudala PJ, Fiellin DA. Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users. Addiction. 2005;100:150\u20138.","journal-title":"Addiction"},{"key":"2764_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0190941","volume":"13","author":"BX Tran","year":"2018","unstructured":"Tran BX, Nguyen LH, Tran TT, Latkin CA. Social and structural barriers for adherence to methadone maintenance treatment among Vietnamese opioid dependence patients. PLoS One. 2018;13:e0190941.","journal-title":"PLoS One"},{"key":"2764_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-016-0127-9","volume":"14","author":"H Van Nguyen","year":"2017","unstructured":"Van Nguyen H, Nguyen HL, Mai HT, Le HQ, Tran BX, Hoang CD, Le HT, Nguyen CT, Tran TD, Latkin CA, Vu TM. StigMMTization among methadone maintenance treatment patients in mountainous areas in northern Vietnam. Harm Reduct J. 2017;14:1.","journal-title":"Harm Reduct J"},{"key":"2764_CR35","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1377\/hlthaff.2011.0663","volume":"30","author":"ND Volkow","year":"2011","unstructured":"Volkow ND, Montaner J. The urgency of providing comprehensive and integrated treatment for substance abusers with HIV. Health Aff. 2011;30:1411\u20139.","journal-title":"Health Aff"},{"key":"2764_CR36","volume-title":"Operational guidelines for the management of opioid dependence in the South-East Asia region","author":"World Health Organization, Regional Office for South-East Asia","year":"2008","unstructured":"World Health Organization, Regional Office for South-East Asia. Operational guidelines for the management of opioid dependence in the South-East Asia region. New Delhi: WHO Regional Office for South-East Asia; 2008."},{"key":"2764_CR37","doi-asserted-by":"publisher","first-page":"e68906","DOI":"10.1371\/journal.pone.0068906","volume":"8","author":"L Zhang","year":"2013","unstructured":"Zhang L, Chow EP, Zhuang X, Liang Y, Wang Y, Tang C, Ling L, Tucker JD, Wilson DP. Methadone maintenance treatment participant retention and behavioural effectiveness in China: a systeMMTic review and meta-analysis. PLoS One. 2013;8:e68906.","journal-title":"PLoS One"},{"key":"2764_CR38","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/ADM.0000000000000263","volume":"11","author":"K Zhou","year":"2017","unstructured":"Zhou K, Li H, Wei X, Li X, Zhuang G. Medication adherence in patients undergoing methadone maintenance treatment in Xi'an, China. J Addict Med. 2017;11:28\u201333.","journal-title":"J Addict Med"}],"updated-by":[{"DOI":"10.1186\/s12888-021-03161-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T00:00:00Z","timestamp":1616457600000}}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-020-02764-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-020-02764-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-020-02764-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T20:16:33Z","timestamp":1627676193000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-020-02764-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,2]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2764"],"URL":"https:\/\/doi.org\/10.1186\/s12888-020-02764-0","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12888-021-03161-x","asserted-by":"object"}]},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,2]]},"assertion":[{"value":"24 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12888-021-03161-x","URL":"https:\/\/doi.org\/10.1186\/s12888-021-03161-x","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study protocol was reviewed and approved by the Research Ethics Committee at National Chang Hua Normal University (no. NCUEREC-103-013). All analyses utilized a de-identified national data set. Individual level consent was not possible nor was it determined not to be necessary by the Ethics Committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"We have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"346"}}